nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—Benzphetamine—Tamoxifen—pancreatic cancer	0.252	1	CrCrCtD
Amphetamine—SLC22A3—Irinotecan—pancreatic cancer	0.185	0.399	CbGbCtD
Amphetamine—CYP2A6—Tamoxifen—pancreatic cancer	0.113	0.245	CbGbCtD
Amphetamine—CYP2A6—Fluorouracil—pancreatic cancer	0.0836	0.181	CbGbCtD
Amphetamine—CYP2D6—Tamoxifen—pancreatic cancer	0.0357	0.0771	CbGbCtD
Amphetamine—CYP2D6—Erlotinib—pancreatic cancer	0.0303	0.0656	CbGbCtD
Amphetamine—CYP2D6—Doxorubicin—pancreatic cancer	0.015	0.0324	CbGbCtD
Amphetamine—Dyspnoea—Erlotinib—pancreatic cancer	0.000617	0.00339	CcSEcCtD
Amphetamine—Dyspepsia—Tamoxifen—pancreatic cancer	0.000616	0.00338	CcSEcCtD
Amphetamine—Dry mouth—Sunitinib—pancreatic cancer	0.000611	0.00336	CcSEcCtD
Amphetamine—Dyspepsia—Erlotinib—pancreatic cancer	0.000609	0.00335	CcSEcCtD
Amphetamine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000608	0.00334	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Tamoxifen—pancreatic cancer	0.000604	0.00332	CcSEcCtD
Amphetamine—Fatigue—Tamoxifen—pancreatic cancer	0.000603	0.00331	CcSEcCtD
Amphetamine—Decreased appetite—Erlotinib—pancreatic cancer	0.000602	0.00331	CcSEcCtD
Amphetamine—Constipation—Tamoxifen—pancreatic cancer	0.000598	0.00329	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Erlotinib—pancreatic cancer	0.000598	0.00328	CcSEcCtD
Amphetamine—Fatigue—Erlotinib—pancreatic cancer	0.000597	0.00328	CcSEcCtD
Amphetamine—Infection—Sunitinib—pancreatic cancer	0.000595	0.00327	CcSEcCtD
Amphetamine—Constipation—Erlotinib—pancreatic cancer	0.000592	0.00325	CcSEcCtD
Amphetamine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.000572	0.00314	CcSEcCtD
Amphetamine—Anorexia—Sunitinib—pancreatic cancer	0.000571	0.00314	CcSEcCtD
Amphetamine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000566	0.00311	CcSEcCtD
Amphetamine—Urticaria—Tamoxifen—pancreatic cancer	0.000556	0.00305	CcSEcCtD
Amphetamine—Abdominal pain—Tamoxifen—pancreatic cancer	0.000553	0.00304	CcSEcCtD
Amphetamine—Abdominal pain—Erlotinib—pancreatic cancer	0.000547	0.00301	CcSEcCtD
Amphetamine—Body temperature increased—Erlotinib—pancreatic cancer	0.000547	0.00301	CcSEcCtD
Amphetamine—Weight decreased—Docetaxel—pancreatic cancer	0.000543	0.00298	CcSEcCtD
Amphetamine—Insomnia—Sunitinib—pancreatic cancer	0.000542	0.00298	CcSEcCtD
Amphetamine—Dyspnoea—Sunitinib—pancreatic cancer	0.000534	0.00294	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00053	0.00291	CcSEcCtD
Amphetamine—Dyspepsia—Sunitinib—pancreatic cancer	0.000527	0.0029	CcSEcCtD
Amphetamine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000527	0.0029	CcSEcCtD
Amphetamine—Myocardial infarction—Docetaxel—pancreatic cancer	0.000524	0.00288	CcSEcCtD
Amphetamine—Hypertension—Irinotecan—pancreatic cancer	0.000522	0.00287	CcSEcCtD
Amphetamine—Decreased appetite—Sunitinib—pancreatic cancer	0.000521	0.00286	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000517	0.00284	CcSEcCtD
Amphetamine—Fatigue—Sunitinib—pancreatic cancer	0.000517	0.00284	CcSEcCtD
Amphetamine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000515	0.00283	CcSEcCtD
Amphetamine—Constipation—Sunitinib—pancreatic cancer	0.000512	0.00282	CcSEcCtD
Amphetamine—Hypertension—Gemcitabine—pancreatic cancer	0.000509	0.00279	CcSEcCtD
Amphetamine—Asthenia—Tamoxifen—pancreatic cancer	0.000502	0.00276	CcSEcCtD
Amphetamine—Convulsion—Fluorouracil—pancreatic cancer	0.000502	0.00276	CcSEcCtD
Amphetamine—Chest pain—Gemcitabine—pancreatic cancer	0.000502	0.00276	CcSEcCtD
Amphetamine—Asthenia—Erlotinib—pancreatic cancer	0.000497	0.00273	CcSEcCtD
Amphetamine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000494	0.00271	CcSEcCtD
Amphetamine—Chest pain—Fluorouracil—pancreatic cancer	0.000493	0.00271	CcSEcCtD
Amphetamine—Infection—Irinotecan—pancreatic cancer	0.00049	0.00269	CcSEcCtD
Amphetamine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00049	0.00269	CcSEcCtD
Amphetamine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000481	0.00264	CcSEcCtD
Amphetamine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000479	0.00263	CcSEcCtD
Amphetamine—Cerebrovascular accident—Epirubicin—pancreatic cancer	0.000478	0.00263	CcSEcCtD
Amphetamine—Infection—Gemcitabine—pancreatic cancer	0.000478	0.00262	CcSEcCtD
Amphetamine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000477	0.00262	CcSEcCtD
Amphetamine—Abdominal pain—Sunitinib—pancreatic cancer	0.000474	0.0026	CcSEcCtD
Amphetamine—Body temperature increased—Sunitinib—pancreatic cancer	0.000474	0.0026	CcSEcCtD
Amphetamine—Diarrhoea—Erlotinib—pancreatic cancer	0.000474	0.0026	CcSEcCtD
Amphetamine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000473	0.0026	CcSEcCtD
Amphetamine—Anorexia—Irinotecan—pancreatic cancer	0.000471	0.00259	CcSEcCtD
Amphetamine—Infection—Fluorouracil—pancreatic cancer	0.00047	0.00258	CcSEcCtD
Amphetamine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000465	0.00255	CcSEcCtD
Amphetamine—Dizziness—Tamoxifen—pancreatic cancer	0.000463	0.00254	CcSEcCtD
Amphetamine—Tachycardia—Fluorouracil—pancreatic cancer	0.000461	0.00254	CcSEcCtD
Amphetamine—Affect lability—Epirubicin—pancreatic cancer	0.000461	0.00253	CcSEcCtD
Amphetamine—Anorexia—Gemcitabine—pancreatic cancer	0.000458	0.00252	CcSEcCtD
Amphetamine—Dizziness—Erlotinib—pancreatic cancer	0.000458	0.00252	CcSEcCtD
Amphetamine—Erythema multiforme—Docetaxel—pancreatic cancer	0.000454	0.0025	CcSEcCtD
Amphetamine—Anorexia—Fluorouracil—pancreatic cancer	0.000451	0.00248	CcSEcCtD
Amphetamine—Insomnia—Irinotecan—pancreatic cancer	0.000446	0.00245	CcSEcCtD
Amphetamine—Vomiting—Tamoxifen—pancreatic cancer	0.000445	0.00244	CcSEcCtD
Amphetamine—Mood swings—Epirubicin—pancreatic cancer	0.000444	0.00244	CcSEcCtD
Amphetamine—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000442	0.00243	CcSEcCtD
Amphetamine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000441	0.00243	CcSEcCtD
Amphetamine—Rash—Tamoxifen—pancreatic cancer	0.000441	0.00242	CcSEcCtD
Amphetamine—Dermatitis—Tamoxifen—pancreatic cancer	0.000441	0.00242	CcSEcCtD
Amphetamine—Vomiting—Erlotinib—pancreatic cancer	0.00044	0.00242	CcSEcCtD
Amphetamine—Dyspnoea—Irinotecan—pancreatic cancer	0.00044	0.00242	CcSEcCtD
Amphetamine—Somnolence—Irinotecan—pancreatic cancer	0.000439	0.00241	CcSEcCtD
Amphetamine—Headache—Tamoxifen—pancreatic cancer	0.000438	0.00241	CcSEcCtD
Amphetamine—Rash—Erlotinib—pancreatic cancer	0.000436	0.0024	CcSEcCtD
Amphetamine—Dermatitis—Erlotinib—pancreatic cancer	0.000436	0.0024	CcSEcCtD
Amphetamine—Insomnia—Gemcitabine—pancreatic cancer	0.000435	0.00239	CcSEcCtD
Amphetamine—Dyspepsia—Irinotecan—pancreatic cancer	0.000435	0.00239	CcSEcCtD
Amphetamine—Headache—Erlotinib—pancreatic cancer	0.000434	0.00238	CcSEcCtD
Amphetamine—Asthenia—Sunitinib—pancreatic cancer	0.00043	0.00236	CcSEcCtD
Amphetamine—Decreased appetite—Irinotecan—pancreatic cancer	0.000429	0.00236	CcSEcCtD
Amphetamine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000429	0.00236	CcSEcCtD
Amphetamine—Abdominal pain upper—Epirubicin—pancreatic cancer	0.000428	0.00235	CcSEcCtD
Amphetamine—Insomnia—Fluorouracil—pancreatic cancer	0.000428	0.00235	CcSEcCtD
Amphetamine—Somnolence—Gemcitabine—pancreatic cancer	0.000427	0.00235	CcSEcCtD
Amphetamine—Affect lability—Doxorubicin—pancreatic cancer	0.000426	0.00234	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000426	0.00234	CcSEcCtD
Amphetamine—Fatigue—Irinotecan—pancreatic cancer	0.000426	0.00234	CcSEcCtD
Amphetamine—Constipation—Irinotecan—pancreatic cancer	0.000422	0.00232	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000422	0.00232	CcSEcCtD
Amphetamine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000421	0.00232	CcSEcCtD
Amphetamine—Somnolence—Fluorouracil—pancreatic cancer	0.00042	0.00231	CcSEcCtD
Amphetamine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000418	0.0023	CcSEcCtD
Amphetamine—Dyspepsia—Fluorouracil—pancreatic cancer	0.000416	0.00229	CcSEcCtD
Amphetamine—Nausea—Tamoxifen—pancreatic cancer	0.000416	0.00228	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000415	0.00228	CcSEcCtD
Amphetamine—Fatigue—Gemcitabine—pancreatic cancer	0.000415	0.00228	CcSEcCtD
Amphetamine—Constipation—Gemcitabine—pancreatic cancer	0.000411	0.00226	CcSEcCtD
Amphetamine—Nausea—Erlotinib—pancreatic cancer	0.000411	0.00226	CcSEcCtD
Amphetamine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000411	0.00226	CcSEcCtD
Amphetamine—Mood swings—Doxorubicin—pancreatic cancer	0.00041	0.00226	CcSEcCtD
Amphetamine—Diarrhoea—Sunitinib—pancreatic cancer	0.00041	0.00225	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000408	0.00224	CcSEcCtD
Amphetamine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000404	0.00222	CcSEcCtD
Amphetamine—Dizziness—Sunitinib—pancreatic cancer	0.000396	0.00218	CcSEcCtD
Amphetamine—Abdominal pain upper—Doxorubicin—pancreatic cancer	0.000396	0.00217	CcSEcCtD
Amphetamine—Body temperature increased—Irinotecan—pancreatic cancer	0.00039	0.00214	CcSEcCtD
Amphetamine—Abdominal pain—Irinotecan—pancreatic cancer	0.00039	0.00214	CcSEcCtD
Amphetamine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.00039	0.00214	CcSEcCtD
Amphetamine—Vomiting—Sunitinib—pancreatic cancer	0.000381	0.00209	CcSEcCtD
Amphetamine—Body temperature increased—Gemcitabine—pancreatic cancer	0.00038	0.00209	CcSEcCtD
Amphetamine—Rash—Sunitinib—pancreatic cancer	0.000378	0.00208	CcSEcCtD
Amphetamine—Dermatitis—Sunitinib—pancreatic cancer	0.000377	0.00207	CcSEcCtD
Amphetamine—Urticaria—Fluorouracil—pancreatic cancer	0.000376	0.00206	CcSEcCtD
Amphetamine—Headache—Sunitinib—pancreatic cancer	0.000375	0.00206	CcSEcCtD
Amphetamine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000374	0.00205	CcSEcCtD
Amphetamine—Palpitations—Docetaxel—pancreatic cancer	0.000369	0.00203	CcSEcCtD
Amphetamine—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000369	0.00203	CcSEcCtD
Amphetamine—Weight decreased—Epirubicin—pancreatic cancer	0.000366	0.00201	CcSEcCtD
Amphetamine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000364	0.002	CcSEcCtD
Amphetamine—Convulsion—Docetaxel—pancreatic cancer	0.000362	0.00199	CcSEcCtD
Amphetamine—Hypertension—Docetaxel—pancreatic cancer	0.000361	0.00198	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000358	0.00197	CcSEcCtD
Amphetamine—Chest pain—Docetaxel—pancreatic cancer	0.000356	0.00196	CcSEcCtD
Amphetamine—Nausea—Sunitinib—pancreatic cancer	0.000356	0.00196	CcSEcCtD
Amphetamine—Asthenia—Irinotecan—pancreatic cancer	0.000354	0.00195	CcSEcCtD
Amphetamine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000351	0.00193	CcSEcCtD
Amphetamine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000348	0.00191	CcSEcCtD
Amphetamine—Dry mouth—Docetaxel—pancreatic cancer	0.000348	0.00191	CcSEcCtD
Amphetamine—Sweating—Epirubicin—pancreatic cancer	0.000346	0.0019	CcSEcCtD
Amphetamine—Asthenia—Gemcitabine—pancreatic cancer	0.000345	0.0019	CcSEcCtD
Amphetamine—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000342	0.00188	CcSEcCtD
Amphetamine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000341	0.00187	CcSEcCtD
Amphetamine—Infection—Docetaxel—pancreatic cancer	0.000339	0.00186	CcSEcCtD
Amphetamine—Weight decreased—Doxorubicin—pancreatic cancer	0.000339	0.00186	CcSEcCtD
Amphetamine—Diarrhoea—Irinotecan—pancreatic cancer	0.000338	0.00186	CcSEcCtD
Amphetamine—Tachycardia—Docetaxel—pancreatic cancer	0.000333	0.00183	CcSEcCtD
Amphetamine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000331	0.00182	CcSEcCtD
Amphetamine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000329	0.00181	CcSEcCtD
Amphetamine—Dizziness—Irinotecan—pancreatic cancer	0.000326	0.00179	CcSEcCtD
Amphetamine—Anorexia—Docetaxel—pancreatic cancer	0.000325	0.00179	CcSEcCtD
Amphetamine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000325	0.00178	CcSEcCtD
Amphetamine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000323	0.00178	CcSEcCtD
Amphetamine—Sweating—Doxorubicin—pancreatic cancer	0.00032	0.00176	CcSEcCtD
Amphetamine—Vomiting—Irinotecan—pancreatic cancer	0.000314	0.00172	CcSEcCtD
Amphetamine—Dizziness—Fluorouracil—pancreatic cancer	0.000313	0.00172	CcSEcCtD
Amphetamine—Rash—Irinotecan—pancreatic cancer	0.000311	0.00171	CcSEcCtD
Amphetamine—Dermatitis—Irinotecan—pancreatic cancer	0.000311	0.00171	CcSEcCtD
Amphetamine—Headache—Irinotecan—pancreatic cancer	0.000309	0.0017	CcSEcCtD
Amphetamine—Insomnia—Docetaxel—pancreatic cancer	0.000309	0.0017	CcSEcCtD
Amphetamine—Erythema multiforme—Epirubicin—pancreatic cancer	0.000306	0.00168	CcSEcCtD
Amphetamine—Vomiting—Gemcitabine—pancreatic cancer	0.000306	0.00168	CcSEcCtD
Amphetamine—Dyspnoea—Docetaxel—pancreatic cancer	0.000304	0.00167	CcSEcCtD
Amphetamine—Somnolence—Docetaxel—pancreatic cancer	0.000303	0.00167	CcSEcCtD
Amphetamine—Rash—Gemcitabine—pancreatic cancer	0.000303	0.00167	CcSEcCtD
Amphetamine—Dermatitis—Gemcitabine—pancreatic cancer	0.000303	0.00166	CcSEcCtD
Amphetamine—Headache—Gemcitabine—pancreatic cancer	0.000301	0.00166	CcSEcCtD
Amphetamine—Vomiting—Fluorouracil—pancreatic cancer	0.000301	0.00165	CcSEcCtD
Amphetamine—Dyspepsia—Docetaxel—pancreatic cancer	0.0003	0.00165	CcSEcCtD
Amphetamine—Rash—Fluorouracil—pancreatic cancer	0.000298	0.00164	CcSEcCtD
Amphetamine—Dermatitis—Fluorouracil—pancreatic cancer	0.000298	0.00164	CcSEcCtD
Amphetamine—Decreased appetite—Docetaxel—pancreatic cancer	0.000297	0.00163	CcSEcCtD
Amphetamine—Headache—Fluorouracil—pancreatic cancer	0.000296	0.00163	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000295	0.00162	CcSEcCtD
Amphetamine—Fatigue—Docetaxel—pancreatic cancer	0.000294	0.00162	CcSEcCtD
Amphetamine—Nausea—Irinotecan—pancreatic cancer	0.000293	0.00161	CcSEcCtD
Amphetamine—Constipation—Docetaxel—pancreatic cancer	0.000292	0.0016	CcSEcCtD
Amphetamine—Nausea—Gemcitabine—pancreatic cancer	0.000286	0.00157	CcSEcCtD
Amphetamine—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000283	0.00156	CcSEcCtD
Amphetamine—Nausea—Fluorouracil—pancreatic cancer	0.000281	0.00154	CcSEcCtD
Amphetamine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000279	0.00153	CcSEcCtD
Amphetamine—Tension—Epirubicin—pancreatic cancer	0.000277	0.00152	CcSEcCtD
Amphetamine—Nervousness—Epirubicin—pancreatic cancer	0.000274	0.0015	CcSEcCtD
Amphetamine—Abdominal pain—Docetaxel—pancreatic cancer	0.00027	0.00148	CcSEcCtD
Amphetamine—Body temperature increased—Docetaxel—pancreatic cancer	0.00027	0.00148	CcSEcCtD
Amphetamine—Agitation—Epirubicin—pancreatic cancer	0.000259	0.00142	CcSEcCtD
Amphetamine—Tension—Doxorubicin—pancreatic cancer	0.000256	0.00141	CcSEcCtD
Amphetamine—Nervousness—Doxorubicin—pancreatic cancer	0.000253	0.00139	CcSEcCtD
Amphetamine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000251	0.00138	CcSEcCtD
Amphetamine—Palpitations—Epirubicin—pancreatic cancer	0.000249	0.00137	CcSEcCtD
Amphetamine—Asthenia—Docetaxel—pancreatic cancer	0.000245	0.00135	CcSEcCtD
Amphetamine—Convulsion—Epirubicin—pancreatic cancer	0.000244	0.00134	CcSEcCtD
Amphetamine—Hypertension—Epirubicin—pancreatic cancer	0.000243	0.00134	CcSEcCtD
Amphetamine—Chest pain—Epirubicin—pancreatic cancer	0.00024	0.00132	CcSEcCtD
Amphetamine—Agitation—Doxorubicin—pancreatic cancer	0.00024	0.00132	CcSEcCtD
Amphetamine—Anxiety—Epirubicin—pancreatic cancer	0.000239	0.00131	CcSEcCtD
Amphetamine—Dry mouth—Epirubicin—pancreatic cancer	0.000235	0.00129	CcSEcCtD
Amphetamine—Diarrhoea—Docetaxel—pancreatic cancer	0.000233	0.00128	CcSEcCtD
Amphetamine—Palpitations—Doxorubicin—pancreatic cancer	0.000231	0.00127	CcSEcCtD
Amphetamine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.00023	0.00126	CcSEcCtD
Amphetamine—Infection—Epirubicin—pancreatic cancer	0.000229	0.00126	CcSEcCtD
Amphetamine—Convulsion—Doxorubicin—pancreatic cancer	0.000226	0.00124	CcSEcCtD
Amphetamine—Dizziness—Docetaxel—pancreatic cancer	0.000226	0.00124	CcSEcCtD
Amphetamine—Hypertension—Doxorubicin—pancreatic cancer	0.000225	0.00124	CcSEcCtD
Amphetamine—Tachycardia—Epirubicin—pancreatic cancer	0.000225	0.00123	CcSEcCtD
Amphetamine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000222	0.00122	CcSEcCtD
Amphetamine—Chest pain—Doxorubicin—pancreatic cancer	0.000222	0.00122	CcSEcCtD
Amphetamine—Anxiety—Doxorubicin—pancreatic cancer	0.000221	0.00122	CcSEcCtD
Amphetamine—Anorexia—Epirubicin—pancreatic cancer	0.000219	0.00121	CcSEcCtD
Amphetamine—Dry mouth—Doxorubicin—pancreatic cancer	0.000217	0.00119	CcSEcCtD
Amphetamine—Vomiting—Docetaxel—pancreatic cancer	0.000217	0.00119	CcSEcCtD
Amphetamine—Rash—Docetaxel—pancreatic cancer	0.000215	0.00118	CcSEcCtD
Amphetamine—Dermatitis—Docetaxel—pancreatic cancer	0.000215	0.00118	CcSEcCtD
Amphetamine—Headache—Docetaxel—pancreatic cancer	0.000214	0.00117	CcSEcCtD
Amphetamine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000213	0.00117	CcSEcCtD
Amphetamine—Infection—Doxorubicin—pancreatic cancer	0.000212	0.00116	CcSEcCtD
Amphetamine—Insomnia—Epirubicin—pancreatic cancer	0.000208	0.00114	CcSEcCtD
Amphetamine—Tachycardia—Doxorubicin—pancreatic cancer	0.000208	0.00114	CcSEcCtD
Amphetamine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000206	0.00113	CcSEcCtD
Amphetamine—Dyspnoea—Epirubicin—pancreatic cancer	0.000205	0.00113	CcSEcCtD
Amphetamine—Somnolence—Epirubicin—pancreatic cancer	0.000205	0.00112	CcSEcCtD
Amphetamine—Anorexia—Doxorubicin—pancreatic cancer	0.000203	0.00112	CcSEcCtD
Amphetamine—Nausea—Docetaxel—pancreatic cancer	0.000203	0.00111	CcSEcCtD
Amphetamine—Dyspepsia—Epirubicin—pancreatic cancer	0.000203	0.00111	CcSEcCtD
Amphetamine—Decreased appetite—Epirubicin—pancreatic cancer	0.0002	0.0011	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000199	0.00109	CcSEcCtD
Amphetamine—Fatigue—Epirubicin—pancreatic cancer	0.000198	0.00109	CcSEcCtD
Amphetamine—Constipation—Epirubicin—pancreatic cancer	0.000197	0.00108	CcSEcCtD
Amphetamine—Insomnia—Doxorubicin—pancreatic cancer	0.000193	0.00106	CcSEcCtD
Amphetamine—Dyspnoea—Doxorubicin—pancreatic cancer	0.00019	0.00104	CcSEcCtD
Amphetamine—Somnolence—Doxorubicin—pancreatic cancer	0.000189	0.00104	CcSEcCtD
Amphetamine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000188	0.00103	CcSEcCtD
Amphetamine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000187	0.00103	CcSEcCtD
Amphetamine—Decreased appetite—Doxorubicin—pancreatic cancer	0.000185	0.00102	CcSEcCtD
Amphetamine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000184	0.00101	CcSEcCtD
Amphetamine—Fatigue—Doxorubicin—pancreatic cancer	0.000184	0.00101	CcSEcCtD
Amphetamine—Urticaria—Epirubicin—pancreatic cancer	0.000183	0.001	CcSEcCtD
Amphetamine—Constipation—Doxorubicin—pancreatic cancer	0.000182	0.001	CcSEcCtD
Amphetamine—Body temperature increased—Epirubicin—pancreatic cancer	0.000182	0.001	CcSEcCtD
Amphetamine—Abdominal pain—Epirubicin—pancreatic cancer	0.000182	0.001	CcSEcCtD
Amphetamine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000174	0.000957	CcSEcCtD
Amphetamine—Hypersensitivity—Epirubicin—pancreatic cancer	0.00017	0.000932	CcSEcCtD
Amphetamine—Urticaria—Doxorubicin—pancreatic cancer	0.000169	0.00093	CcSEcCtD
Amphetamine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000168	0.000925	CcSEcCtD
Amphetamine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000168	0.000925	CcSEcCtD
Amphetamine—Asthenia—Epirubicin—pancreatic cancer	0.000165	0.000907	CcSEcCtD
Amphetamine—Diarrhoea—Epirubicin—pancreatic cancer	0.000157	0.000865	CcSEcCtD
Amphetamine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000157	0.000862	CcSEcCtD
Amphetamine—Asthenia—Doxorubicin—pancreatic cancer	0.000153	0.00084	CcSEcCtD
Amphetamine—Dizziness—Epirubicin—pancreatic cancer	0.000152	0.000836	CcSEcCtD
Amphetamine—Vomiting—Epirubicin—pancreatic cancer	0.000146	0.000804	CcSEcCtD
Amphetamine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000146	0.000801	CcSEcCtD
Amphetamine—Rash—Epirubicin—pancreatic cancer	0.000145	0.000797	CcSEcCtD
Amphetamine—Dermatitis—Epirubicin—pancreatic cancer	0.000145	0.000797	CcSEcCtD
Amphetamine—Headache—Epirubicin—pancreatic cancer	0.000144	0.000792	CcSEcCtD
Amphetamine—Dizziness—Doxorubicin—pancreatic cancer	0.000141	0.000774	CcSEcCtD
Amphetamine—Nausea—Epirubicin—pancreatic cancer	0.000137	0.000751	CcSEcCtD
Amphetamine—Vomiting—Doxorubicin—pancreatic cancer	0.000135	0.000744	CcSEcCtD
Amphetamine—Rash—Doxorubicin—pancreatic cancer	0.000134	0.000738	CcSEcCtD
Amphetamine—Dermatitis—Doxorubicin—pancreatic cancer	0.000134	0.000737	CcSEcCtD
Amphetamine—Headache—Doxorubicin—pancreatic cancer	0.000133	0.000733	CcSEcCtD
Amphetamine—Nausea—Doxorubicin—pancreatic cancer	0.000126	0.000695	CcSEcCtD
Amphetamine—DRD2—GPCR downstream signaling—SSTR1—pancreatic cancer	7.81e-05	0.000759	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CD—pancreatic cancer	7.75e-05	0.000753	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—pancreatic cancer	7.7e-05	0.000747	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PPY—pancreatic cancer	7.66e-05	0.000744	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—SST—pancreatic cancer	7.57e-05	0.000735	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GLP1R—pancreatic cancer	7.54e-05	0.000732	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—SSTR2—pancreatic cancer	7.52e-05	0.00073	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—TGFB1—pancreatic cancer	7.47e-05	0.000726	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PIK3CB—pancreatic cancer	7.44e-05	0.000723	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—DPYD—pancreatic cancer	7.42e-05	0.00072	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SSTR3—pancreatic cancer	7.4e-05	0.000719	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCKBR—pancreatic cancer	7.26e-05	0.000705	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PPARG—pancreatic cancer	7.24e-05	0.000703	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SMAD4—pancreatic cancer	7.23e-05	0.000702	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.15e-05	0.000694	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SSTR1—pancreatic cancer	7.09e-05	0.000689	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HES1—pancreatic cancer	7.06e-05	0.000685	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—SLC2A2—pancreatic cancer	7.04e-05	0.000684	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CNR1—pancreatic cancer	6.99e-05	0.000679	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PPY—pancreatic cancer	6.96e-05	0.000676	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SSTR2—pancreatic cancer	6.83e-05	0.000663	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	6.8e-05	0.00066	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CB—pancreatic cancer	6.76e-05	0.000656	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GCG—pancreatic cancer	6.75e-05	0.000656	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFB1—pancreatic cancer	6.62e-05	0.000643	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCKBR—pancreatic cancer	6.59e-05	0.00064	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCL8—pancreatic cancer	6.49e-05	0.000631	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—AGTR1—pancreatic cancer	6.44e-05	0.000625	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GLP1R—pancreatic cancer	6.38e-05	0.000619	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—DPYD—pancreatic cancer	6.28e-05	0.000609	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GAST—pancreatic cancer	6.24e-05	0.000606	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TERT—pancreatic cancer	6.18e-05	0.0006	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRSS1—pancreatic cancer	6.01e-05	0.000584	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—SLC2A2—pancreatic cancer	5.96e-05	0.000578	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—SCT—pancreatic cancer	5.92e-05	0.000575	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HIF1A—pancreatic cancer	5.91e-05	0.000574	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TSC2—pancreatic cancer	5.9e-05	0.000573	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—APOE—pancreatic cancer	5.77e-05	0.00056	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GAST—pancreatic cancer	5.67e-05	0.000551	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KDR—pancreatic cancer	5.65e-05	0.000549	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCK—pancreatic cancer	5.65e-05	0.000548	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—TP53—pancreatic cancer	5.54e-05	0.000538	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—pancreatic cancer	5.53e-05	0.000537	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GLP1R—pancreatic cancer	5.5e-05	0.000534	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR2—pancreatic cancer	5.5e-05	0.000534	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—CD44—pancreatic cancer	5.45e-05	0.000529	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCKAR—pancreatic cancer	5.41e-05	0.000526	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NFKBIA—pancreatic cancer	5.38e-05	0.000522	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SCT—pancreatic cancer	5.38e-05	0.000522	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NOTCH1—pancreatic cancer	5.33e-05	0.000517	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GCG—pancreatic cancer	5.23e-05	0.000507	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ARG2—pancreatic cancer	5.21e-05	0.000506	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CG—pancreatic cancer	5.21e-05	0.000506	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—NRAS—pancreatic cancer	5.21e-05	0.000506	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—HRAS—pancreatic cancer	5.21e-05	0.000506	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGF—pancreatic cancer	5.15e-05	0.0005	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PRLHR—pancreatic cancer	5.14e-05	0.000499	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCK—pancreatic cancer	5.13e-05	0.000498	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR2—pancreatic cancer	5e-05	0.000485	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GLP1R—pancreatic cancer	5e-05	0.000485	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PTEN—pancreatic cancer	4.97e-05	0.000482	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCKAR—pancreatic cancer	4.92e-05	0.000477	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—STK11—pancreatic cancer	4.91e-05	0.000477	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—IAPP—pancreatic cancer	4.88e-05	0.000473	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL8—pancreatic cancer	4.87e-05	0.000473	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ZNRF3—pancreatic cancer	4.83e-05	0.000469	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—ACVR1B—pancreatic cancer	4.83e-05	0.000469	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—EGFR—pancreatic cancer	4.75e-05	0.000461	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTHLH—pancreatic cancer	4.68e-05	0.000454	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—CD44—pancreatic cancer	4.61e-05	0.000448	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CD—pancreatic cancer	4.58e-05	0.000445	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TYMP—pancreatic cancer	4.56e-05	0.000442	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.54e-05	0.00044	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—KRAS—pancreatic cancer	4.48e-05	0.000435	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SHH—pancreatic cancer	4.48e-05	0.000435	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IAPP—pancreatic cancer	4.43e-05	0.00043	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GCG—pancreatic cancer	4.42e-05	0.000429	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SSTR3—pancreatic cancer	4.37e-05	0.000424	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DTX1—pancreatic cancer	4.37e-05	0.000424	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—SST—pancreatic cancer	4.28e-05	0.000416	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTHLH—pancreatic cancer	4.25e-05	0.000413	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTCH1—pancreatic cancer	4.25e-05	0.000413	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—TYMS—pancreatic cancer	4.23e-05	0.00041	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SSTR1—pancreatic cancer	4.19e-05	0.000407	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—STK11—pancreatic cancer	4.16e-05	0.000404	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.12e-05	0.0004	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PPY—pancreatic cancer	4.11e-05	0.000399	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—pancreatic cancer	4.05e-05	0.000394	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SSTR2—pancreatic cancer	4.03e-05	0.000392	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CB—pancreatic cancer	3.99e-05	0.000388	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR1—pancreatic cancer	3.95e-05	0.000384	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCKBR—pancreatic cancer	3.9e-05	0.000378	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SST—pancreatic cancer	3.89e-05	0.000377	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	3.87e-05	0.000376	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL8—pancreatic cancer	3.84e-05	0.000372	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GCG—pancreatic cancer	3.81e-05	0.00037	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRAS—pancreatic cancer	3.81e-05	0.00037	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—AKT1—pancreatic cancer	3.71e-05	0.00036	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GLP1R—pancreatic cancer	3.67e-05	0.000357	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CASP3—pancreatic cancer	3.67e-05	0.000356	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GLI1—pancreatic cancer	3.66e-05	0.000356	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DTX4—pancreatic cancer	3.66e-05	0.000356	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AGTR1—pancreatic cancer	3.64e-05	0.000353	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—DPYD—pancreatic cancer	3.61e-05	0.000351	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR1—pancreatic cancer	3.59e-05	0.000348	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—TYMS—pancreatic cancer	3.58e-05	0.000347	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCND1—pancreatic cancer	3.57e-05	0.000347	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PPP2R5B—pancreatic cancer	3.56e-05	0.000346	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NRP1—pancreatic cancer	3.56e-05	0.000346	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CTNNB1—pancreatic cancer	3.54e-05	0.000344	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MMP9—pancreatic cancer	3.47e-05	0.000337	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GCG—pancreatic cancer	3.46e-05	0.000336	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTEN—pancreatic cancer	3.45e-05	0.000335	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—APOE—pancreatic cancer	3.44e-05	0.000334	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HEY2—pancreatic cancer	3.43e-05	0.000333	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—SLC2A2—pancreatic cancer	3.43e-05	0.000333	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—TP53—pancreatic cancer	3.39e-05	0.000329	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRSS1—pancreatic cancer	3.37e-05	0.000327	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—AKT1—pancreatic cancer	3.36e-05	0.000327	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GAST—pancreatic cancer	3.35e-05	0.000325	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AGTR1—pancreatic cancer	3.3e-05	0.000321	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SRC—pancreatic cancer	3.2e-05	0.000311	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SCT—pancreatic cancer	3.18e-05	0.000308	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HEY1—pancreatic cancer	3.18e-05	0.000308	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—VEGFA—pancreatic cancer	3.12e-05	0.000303	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—HRAS—pancreatic cancer	3.1e-05	0.000302	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CG—pancreatic cancer	3.1e-05	0.000301	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—STAT3—pancreatic cancer	3.08e-05	0.0003	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NRAS—pancreatic cancer	3.08e-05	0.000299	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCK—pancreatic cancer	3.03e-05	0.000294	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—pancreatic cancer	2.99e-05	0.000291	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR2—pancreatic cancer	2.95e-05	0.000287	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GLP1R—pancreatic cancer	2.95e-05	0.000287	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL8—pancreatic cancer	2.95e-05	0.000287	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ARG2—pancreatic cancer	2.92e-05	0.000284	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—APOE—pancreatic cancer	2.91e-05	0.000282	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCKAR—pancreatic cancer	2.9e-05	0.000282	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MYC—pancreatic cancer	2.87e-05	0.000278	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—pancreatic cancer	2.86e-05	0.000278	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAG2—pancreatic cancer	2.82e-05	0.000274	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—EGFR—pancreatic cancer	2.8e-05	0.000272	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MEN1—pancreatic cancer	2.78e-05	0.00027	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CD—pancreatic cancer	2.73e-05	0.000265	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CD44—pancreatic cancer	2.66e-05	0.000258	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—pancreatic cancer	2.65e-05	0.000257	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SHH—pancreatic cancer	2.65e-05	0.000257	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH4—pancreatic cancer	2.63e-05	0.000256	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CG—pancreatic cancer	2.62e-05	0.000255	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IAPP—pancreatic cancer	2.62e-05	0.000254	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TYMP—pancreatic cancer	2.56e-05	0.000248	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GCG—pancreatic cancer	2.55e-05	0.000247	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—pancreatic cancer	2.53e-05	0.000246	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTHLH—pancreatic cancer	2.51e-05	0.000244	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTCH1—pancreatic cancer	2.51e-05	0.000244	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PIK3CA—pancreatic cancer	2.43e-05	0.000236	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—STK11—pancreatic cancer	2.39e-05	0.000232	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CB—pancreatic cancer	2.38e-05	0.000231	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—pancreatic cancer	2.36e-05	0.000229	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TP53—pancreatic cancer	2.35e-05	0.000229	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CD—pancreatic cancer	2.31e-05	0.000224	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SST—pancreatic cancer	2.3e-05	0.000223	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CG—pancreatic cancer	2.26e-05	0.00022	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—pancreatic cancer	2.25e-05	0.000219	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—JAG1—pancreatic cancer	2.25e-05	0.000218	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH3—pancreatic cancer	2.24e-05	0.000217	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—pancreatic cancer	2.12e-05	0.000206	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GLP1R—pancreatic cancer	2.06e-05	0.0002	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—TYMS—pancreatic cancer	2.06e-05	0.0002	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CG—pancreatic cancer	2.06e-05	0.0002	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTEN—pancreatic cancer	2.05e-05	0.000199	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GCG—pancreatic cancer	2.05e-05	0.000199	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—DPYD—pancreatic cancer	2.03e-05	0.000197	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CB—pancreatic cancer	2.01e-05	0.000195	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—pancreatic cancer	1.99e-05	0.000194	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CD—pancreatic cancer	1.99e-05	0.000193	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—AKT1—pancreatic cancer	1.99e-05	0.000193	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AGTR1—pancreatic cancer	1.95e-05	0.00019	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STK11—pancreatic cancer	1.92e-05	0.000187	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	1.92e-05	0.000187	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CD—pancreatic cancer	1.81e-05	0.000176	CbGpPWpGaD
Amphetamine—Pseudoephedrine—TNF—pancreatic cancer	1.75e-05	0.505	CrCbGaD
Amphetamine—SLC22A3—Metabolism—PTEN—pancreatic cancer	1.74e-05	0.000169	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.74e-05	0.000169	CbGpPWpGaD
Amphetamine—Nateglinide—PPARG—pancreatic cancer	1.72e-05	0.495	CrCbGaD
Amphetamine—DRD2—Signaling Pathways—SMAD4—pancreatic cancer	1.69e-05	0.000164	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—APOE—pancreatic cancer	1.67e-05	0.000163	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—pancreatic cancer	1.67e-05	0.000162	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HES1—pancreatic cancer	1.65e-05	0.00016	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CB—pancreatic cancer	1.58e-05	0.000153	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—pancreatic cancer	1.51e-05	0.000147	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CG—pancreatic cancer	1.51e-05	0.000147	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CD44—pancreatic cancer	1.49e-05	0.000145	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—pancreatic cancer	1.46e-05	0.000142	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PIK3CA—pancreatic cancer	1.45e-05	0.000141	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TERT—pancreatic cancer	1.44e-05	0.00014	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCG—pancreatic cancer	1.43e-05	0.000139	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HIF1A—pancreatic cancer	1.38e-05	0.000134	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TSC2—pancreatic cancer	1.38e-05	0.000134	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—APOE—pancreatic cancer	1.35e-05	0.000131	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—STK11—pancreatic cancer	1.34e-05	0.00013	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CD—pancreatic cancer	1.33e-05	0.000129	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KDR—pancreatic cancer	1.32e-05	0.000128	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NFKBIA—pancreatic cancer	1.25e-05	0.000122	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NOTCH1—pancreatic cancer	1.24e-05	0.000121	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PIK3CA—pancreatic cancer	1.23e-05	0.000119	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CG—pancreatic cancer	1.21e-05	0.000118	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NRAS—pancreatic cancer	1.21e-05	0.000118	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGF—pancreatic cancer	1.2e-05	0.000117	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—AKT1—pancreatic cancer	1.18e-05	0.000115	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CB—pancreatic cancer	1.16e-05	0.000112	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—TYMS—pancreatic cancer	1.15e-05	0.000112	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—pancreatic cancer	1.15e-05	0.000111	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—EGFR—pancreatic cancer	1.11e-05	0.000107	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CD—pancreatic cancer	1.07e-05	0.000104	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.06e-05	0.000103	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—pancreatic cancer	1.05e-05	0.000102	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—AKT1—pancreatic cancer	1e-05	9.73e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTEN—pancreatic cancer	1e-05	9.72e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PIK3CA—pancreatic cancer	9.61e-06	9.33e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—APOE—pancreatic cancer	9.39e-06	9.12e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CB—pancreatic cancer	9.31e-06	9.04e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—pancreatic cancer	8.94e-06	8.69e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—pancreatic cancer	8.89e-06	8.63e-05	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	8.64e-06	8.39e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP3—pancreatic cancer	8.56e-06	8.31e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	8.47e-06	8.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCND1—pancreatic cancer	8.33e-06	8.09e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	8.25e-06	8.01e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—pancreatic cancer	8.18e-06	7.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MMP9—pancreatic cancer	8.09e-06	7.86e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTEN—pancreatic cancer	8.04e-06	7.81e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	7.85e-06	7.62e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SRC—pancreatic cancer	7.46e-06	7.24e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	7.45e-06	7.23e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	7.27e-06	7.06e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—STAT3—pancreatic cancer	7.19e-06	6.99e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NRAS—pancreatic cancer	7.18e-06	6.97e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PIK3CA—pancreatic cancer	7.06e-06	6.85e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MYC—pancreatic cancer	6.68e-06	6.49e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	6.67e-06	6.48e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—EGFR—pancreatic cancer	6.54e-06	6.35e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	6.49e-06	6.31e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—pancreatic cancer	6.43e-06	6.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—pancreatic cancer	6.18e-06	6e-05	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—AKT1—pancreatic cancer	5.77e-06	5.6e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	5.67e-06	5.51e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTEN—pancreatic cancer	5.61e-06	5.45e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TP53—pancreatic cancer	5.49e-06	5.33e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—pancreatic cancer	5.25e-06	5.1e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—AKT1—pancreatic cancer	4.64e-06	4.5e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	3.96e-06	3.84e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—AKT1—pancreatic cancer	3.23e-06	3.14e-05	CbGpPWpGaD
